An Openlabel, Phase II Trial of Abatacept (Orencia) in the Treatment of Refractory Non-infectious Uveitis.
An Openlabel, Phase II Trial of Abatacept (Orencia) in the Treatment of Refractory Non-infectious Uveitis.
The purpose of this study is to assess the safety and efficacy of abatacept in the treatment of uveitis.
Inclusion Criteria:
Exclusion Criteria: